Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial
Boeck, S, Weigang-Köhler, K, Fuchs, M, Kettner, E, Quietzsch, D, Trojan, J, Stötzer, O, Zeuzem, S, Lordick, F, Köhne, C-H, Kröning, H, Steinmetz, T, Depenbrock, H, Heinemann, V
Published in Annals of oncology (01.04.2007)
Published in Annals of oncology (01.04.2007)
Get full text
Journal Article
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer
Bergmann, L, Maute, L, Heil, G, Rüssel, J, Weidmann, E, Köberle, D, Fuxius, S, Weigang-Köhler, K, Aulitzky, W.E, Wörmann, B, Hartung, G, Moritz, B, Edler, L, Burkholder, I, Scheulen, M.E, Richly, H
Published in European journal of cancer (1990) (01.01.2015)
Published in European journal of cancer (1990) (01.01.2015)
Get full text
Journal Article
Pro- versus antitumor effects of bisphosphonate-activated γδ T cells in cancer immunotherapy
Kunzmann, V., Smetak, M., Kimmel, B., Weigang-Koehler, K., Goebeler, M., Birkmann, J., Becker, J., Schmidt-Wolf, I., Einsele, H., Wilhelm, M.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer
Hanauske, A.-R., Lahn, M., Musib, L.C., Weigang-Köhler, K., Yilmaz, E., Graefe, T., Kuenen, B., Thornton, D., McNealy, P., Giaccone, G.
Published in Annals of oncology (01.09.2009)
Published in Annals of oncology (01.09.2009)
Get full text
Journal Article
Pharmacokinetic interaction and safety of enzastaurin and pemetrexed in patients with advanced or metastatic cancer
Hanauske, A., Weigang Koehler, K., Yilmaz, E., Graefe, T., Kuenen, B., Thornton, D., Lahn, M., Darstein, C., Musib, L., Guiseppe, G.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Second-line therapy with pemetrexed after gemcitabine failure in patients with unresectable locally advanced or metastatic pancreatic cancer: A multicenter phase II trial
Boeck, S., Weigang-Koehler, K., Fuchs, M., Kettner, E., Quietzsch, D., Trojan, J., Stötzer, O., Mueller, E., Depenbrock, H., Heinemann, V.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Phase III trial of irinotecan plus oxaliplatin (IROX) versus irinotecan plus 5-FU/folinic acid (FOLFIRI) as first-line treatment of metastatic colorectal cancer (CRC): The FIRE-Trial
Schalhorn, A., Ludwig, F. W., Quietzsch, D., Maubach, P. A., Schlimok, G., Lambertz, H., Weigang-Koehler, K., Schulze, M., Schlag, R., Grundeis, M., Heinemann, V.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article